Protein profiling of cervical cancer by protein-biochips: Proteomic scoring to discriminate cervical cancer from normal cervix

Cancer Letters

Volumn 211, Issue 2, 2004, Pages 227-234

  Wong, Y F ^a   Cheung, T H ^a   Lo, K W K ^a   Wang, V W ^b   Chan, C S ^a   Ng, T B ^c   Chung, T K H ^c   Mok, S C ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cervical cancer; Protein profiling; Surface enhanced laser desorption ionization

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CELL LYSATE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION MASS SPECTROMETRY; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MASS SPECTROMETRY; MIDDLE AGED; NEOPLASM INVASIVENESS; OBSERVER VARIATION; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS;

EID: 3042654894     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.02.014     Document Type: Article

References (11)

1. Chung T.K.H., Cheung T.H., Lo W.K., Yu M.Y., Hampton G.M., Wong H.K.T., Wong Y.F. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia. Cancer Lett. 154:2000;189-194
2. Nguyen G.K., Nguyen P.H., Husain M., Husain E.M. Cervical squamous cell carcinoma and its precursor lesions: cytodiagnostic criteria and pitfalls. Anat. Pathol. 1:1996;139-164
3. Scoell W.M., Janicek M.F., Mirhasphemi R. Epidemiology and biology of cervical cancer. Semin. Surg. Oncol. 16:1999;203-211
4. Lonky N.M. Risk factors related to the development and mortality from invasive cervical cancer: clinical utility and impact on prevention. Obstet. Gynecol. Clin. North Am. 29:2002;817-842
5. Vlahou A., Schellhammer P.F., Mendrinos S., Patel K., Kondylis F.I., Gong L., et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol. 158:2001;1491-1502
6. ® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostate Dis. 2:1999;264-276
7. Hlavaty J.L., Partin A.W., Kusinitz F., Shue M.J., Stieg A., Bennett K., Briggman J.V. Mass spectroscopy as a discovery tool for identifying serum markers for prostate cancer. Clin. Chem. 47:2001;1924-1926
8. Paweletz C.P., Trock B., Pennanen M., Tsangaris T., Magnant C., Liotta L.A., Petricoin E.F. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis. Markers. 17:2001;301-307
9. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 359:2002;572-577
10. Li J., Zhang Z., Rosenzweig J., Wang Y.Y., Chan D.W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 48:2002;1296-1304
11. Ling B.A., Qu Y., Davis J.W., Ward M.D., Clements M.A., Cazares L.H., et al. Serum protein fingerprinting with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia. Cancer Res. 62:2002;3609-3614